News blog
Amyris goes public
Posted on behalf of Yana Balling Amyris Inc, a start-up biotech company specialising in biofuels, raised $85 million in its first public offering yesterday. An estimated 5.3 million shares were sold throughout the day on the NASDAQ Global Market. The company, based in Emeryville, California, had hoped to raise $100 million. Analysts ascribe the disappointing performance to Amyris entering the market too early, before it has commercialised any of its renewable products. But Biofuels Digest declared the glass half-full, saying that the money raised was a ‘hallmark of faith’ in the potential of biofuel technology. Amyris, now with 200 employees,
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells